Braze, Inc. Class A Common Stock
BRZE
$23.07
+0.70%
Braze, Inc. provides a cloud-based customer engagement platform that enables brands to orchestrate personalized marketing campaigns across channels like email, push notifications, and in-app messaging. The company operates as a key player in the Software-as-a-Service (SaaS) sector, focusing on verticals such as Retail & E-commerce, Media & Entertainment, and Financial Services, with its core platform powered by its proprietary Sage AI engine. The current investor narrative is dominated by a recent surge in optimism following a strong quarterly earnings report where the company beat revenue expectations, announced a new share buyback program, and significantly raised its future profit outlook, signaling accelerating growth and a bullish operational trajectory.…
BRZE
Braze, Inc. Class A Common Stock
$23.07
Related headlines
Investment Opinion: Should I buy BRZE Today?
Rating: Buy. The core thesis is that Braze represents a compelling turnaround growth story, where strong fundamental acceleration and a clear path to profitability are occurring at a historically discounted valuation, offering asymmetric risk/reward. The Buy rating is supported by four key data points: 1) Robust 27.9% YoY revenue growth demonstrating product demand, 2) A rapid operating margin improvement from -24.8% to -8.2% in just three quarters, 3) Positive TTM Free Cash Flow of $60.8M enabling self-funded growth and buybacks, and 4) A valuation at 3.04x PS, near historical lows after a -57% drawdown, providing a margin of safety absent in most high-growth SaaS names. The unanimous bullish analyst sentiment post-earnings adds credibility to this view. The two biggest risks are growth deceleration below 20% and a delay in achieving GAAP profitability. This Buy rating would downgrade to Hold if quarterly revenue growth falls below 22% or operating margins fail to improve sequentially. It would downgrade to Sell if growth decelerates below 15% or the stock breaks below its 52-week low of $15.26. Relative to its own history and growth profile, the stock appears fairly valued to slightly undervalued, with the potential for significant re-rating if execution continues.
Sign up to view all
BRZE 12-Month Price Forecast
The AI assessment is bullish with medium confidence, based on a compelling convergence of improving fundamentals, reasonable valuation, and positive momentum. The 28% revenue growth is exceptional, and the rapid margin improvement suggests the path to profitability is credible. The primary reason for medium, not high, confidence is the stock's history of severe volatility and the high expectations embedded in its forward PE of 26x. The stance would upgrade to bullish with high confidence on confirmation of sustained >25% growth and another quarter of margin expansion. It would downgrade to neutral if growth decelerates to the low-20% range or if the stock fails to hold above the $23 support level.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Braze, Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $29.99 and implied upside of +30.0% versus the current price.
Average Target
$29.99
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$18 - $30
Analyst target range
Insufficient analyst coverage data is available in the provided dataset to calculate a precise consensus target price or implied upside. The data shows only 3 analysts providing revenue estimates, with an average estimate of $1.48 billion, but no price targets or recommendation distributions are provided. This limited coverage is typical for a mid-cap, recently public company like Braze, which went public in late 2021. The lack of a broad analyst consensus can lead to higher stock price volatility and less efficient price discovery, as the investment story is less widely disseminated and debated among institutional investors. However, recent institutional ratings data from late March 2026 shows a uniformly bullish sentiment among the firms that do cover the stock. Ten major investment banks, including JP Morgan, Citigroup, Barclays, and Needham, all maintained positive ratings such as Overweight, Outperform, or Buy following the company's strong quarterly report. This unanimous bullish stance from covering analysts, coupled with the significant stock price rally on the news, indicates strong institutional conviction in the near-term trajectory. The absence of a formal target range in the data, however, prevents quantifying the expected upside and leaves the specific price expectations of these analysts unclear.
Bulls vs Bears: BRZE Investment Factors
The evidence currently tilts bullish, driven by a powerful combination of accelerating fundamental growth, rapid margin improvement, and a compelling valuation reset. The most critical tension in the investment debate is the race between Braze's improving fundamentals (28% revenue growth, path to profitability) and its still-elevated valuation multiples (26x forward PE) that demand flawless execution. If the company can sustain its growth trajectory and achieve GAAP profitability as guided, the stock's deep undervaluation relative to its history presents significant upside. However, if growth decelerates or profitability timelines slip, the stock's high multiples could compress further, reigniting the downtrend.
Bullish
- Strong Revenue Growth & Raised Outlook: Braze reported Q4 revenue of $205.17M, a 27.9% YoY increase, and significantly raised its future profit outlook. This accelerating top-line growth, coupled with bullish institutional analyst sentiment following the report, signals a positive operational inflection point.
- Rapid Path to Profitability: The company's operating margin improved dramatically from -24.8% in Q1 to -8.2% in Q4 of the same fiscal year. This sequential improvement, alongside a forward PE of 26.25x, indicates the market is pricing in a near-term transition to GAAP profitability.
- Positive Free Cash Flow & Strong Balance Sheet: Braze generated $60.8M in TTM free cash flow and has a low debt-to-equity ratio of 0.13. This strong financial position funds growth internally, reduces dilution risk, and enabled the announcement of a new share buyback program, signaling management confidence.
- Attractive Valuation Near Historical Lows: The stock trades at a PS ratio of 3.04x, a significant compression from levels above 11x in early 2025. Trading at just 32% of its 52-week range ($15.26-$37.67), it is near the lower end of its historical valuation, offering a potential margin of safety.
Bearish
- Persistent GAAP Losses: Braze reported a Q4 net loss of $31.6M, a -15.4% net margin. Despite margin improvement, the company remains unprofitable, and its forward PE of 26.25x requires flawless execution to justify, leaving no room for operational missteps.
- Severe Long-Term Underperformance: The stock is down 29.67% over the past year, underperforming the SPY by over 57 percentage points, and has a maximum drawdown of -57.2%. This deep, sustained downtrend reflects significant prior investor skepticism that may not be fully resolved.
- High Valuation Multiples Despite Losses: A forward PE of 26.25x and a P/CF of 31.45x are elevated for a company still reporting losses. These multiples imply high growth expectations; any deceleration from the current 28% revenue growth rate could trigger multiple compression.
- Limited Analyst Coverage & Price Discovery: Only 3 analysts provide revenue estimates, and no consensus price target is available. This limited coverage can lead to higher volatility and less efficient price discovery, as the investment narrative is not widely vetted by the institutional community.
BRZE Technical Analysis
The stock is in a pronounced downtrend over the past year, with a 1-year price change of -29.67%, significantly underperforming the broader market (SPY up 28.21%). As of the latest close at $25.63, the price is trading at approximately 32% of its 52-week range ($15.26 to $37.67), indicating it is much closer to its 52-week low than its high, which suggests a potential value opportunity but also reflects significant selling pressure and negative sentiment. The stock's beta of 0.77 indicates it has been less volatile than the market over this period, though its specific drawdown has been severe. Recent momentum shows signs of a potential rebound, with a strong 1-month gain of 12.96% and an even stronger 3-month gain of 34.97%, sharply diverging from the negative annual trend. This positive short-term momentum, which has generated a 6.65% relative strength advantage over the SPY in the last month, could signal the beginning of a trend reversal or a bear market rally, especially given the sharp rally in early March from the lows near $16. The stock's 6-month performance remains negative at -10.70%, highlighting the recent rally's effort to claw back from deeper losses. Key technical support is clearly defined at the 52-week low of $15.26, while resistance sits at the 52-week high of $37.67. A sustained breakout above the recent recovery high near $26 would be needed to challenge higher resistance levels. The stock's beta of 0.77 suggests lower systematic risk than the market, which may appeal to investors seeking growth exposure with slightly dampened volatility, though the stock's own price history shows it is capable of sharp moves, as evidenced by the 57.2% maximum drawdown.
Beta
0.82
0.82x market volatility
Max Drawdown
-57.2%
Largest decline past year
52-Week Range
$15-$38
Price range past year
Annual Return
-22.4%
Cumulative gain past year
| Period | BRZE Return | S&P 500 |
|---|---|---|
| 1m | +6.2% | +0.2% |
| 3m | +23.4% | +9.2% |
| 6m | -36.3% | +7.5% |
| 1y | -22.4% | +23.4% |
| ytd | -29.1% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BRZE Fundamental Analysis
Braze's revenue trajectory remains robustly positive, with the most recent quarterly revenue (Q4 FY26 ending Jan 31, 2026) reaching $205.17 million, representing a 27.9% year-over-year growth. The multi-quarter trend shows consistent top-line expansion, with revenue growing sequentially from $162.06M in Q1 to $205.17M in Q4 of the same fiscal year. The business is overwhelmingly driven by subscription revenue, which constituted $193.5 million (94.3%) of the total last quarter, indicating a highly recurring and scalable model. This sustained growth underpins the investment case for a high-growth SaaS platform. The company is not yet profitable on a GAAP basis, reporting a net loss of $31.6 million in the latest quarter, which equates to a net margin of -15.4%. However, the gross margin remains healthy at 65.5%, typical for a software company. The operating margin was -8.2% in Q4, showing a significant sequential improvement from -24.8% in Q1 of the same fiscal year, indicating the company is making progress on its path to profitability by controlling operating expenses relative to its growing revenue base. The balance sheet and cash flow position show a company funding its growth internally. The company has a strong liquidity position with a current ratio of 1.35 and a modest debt-to-equity ratio of 0.13, indicating low financial leverage. Crucially, Braze generated positive free cash flow of $60.8 million on a trailing twelve-month basis, and the latest quarterly operating cash flow was $19.38 million. The return on equity is deeply negative at -21.0%, which is expected for a growth-stage company reinvesting heavily, but the positive free cash flow generation provides a crucial buffer and reduces dependence on external financing.
Quarterly Revenue
$205170000.0B
2026-01
Revenue YoY Growth
+0.27%
YoY Comparison
Gross Margin
+0.65%
Latest Quarter
Free Cash Flow
$60795000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BRZE Overvalued?
Given the company's negative net income (-$31.6M in the latest quarter), we lead with the Price-to-Sales (PS) ratio for valuation. Braze's trailing PS ratio stands at 3.04x, while its forward-looking valuation can be inferred from its enterprise value to sales (EV/Sales) of 2.96x. The forward PE ratio of 26.25x is also available but is based on projected earnings, highlighting the market's expectation for future profitability. The gap between the negative trailing PE (-17.1x) and the positive forward PE implies the market is pricing in a significant inflection towards profitability. Compared to the broader software industry, a PS ratio of approximately 3.0x is generally considered reasonable for a company growing revenue at nearly 28% annually. While a direct industry average PS ratio is not provided in the data, this multiple suggests the market is valuing Braze's growth while acknowledging its current lack of profitability. The valuation premium or discount is likely justified by its superior growth rate compared to more mature software peers, though tempered by its ongoing losses. Historically, Braze's valuation has contracted significantly from its post-IPO highs. The historical ratios data shows the PS ratio has compressed from levels above 11x in early 2025 to the current ~3x. This places the stock near the lower end of its own historical valuation range, suggesting the market has already priced in significant skepticism. Trading near historical lows could indicate a value opportunity if the company's improved fundamentals and raised guidance materialize, but it also reflects the market's previous over-optimism and subsequent correction.
PE
-17.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -242x~-18x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-17.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on Braze's ongoing losses and the high expectations embedded in its valuation. The company's -15.4% net margin and -21.0% ROE show it is still burning accounting profit, though positive FCF of $60.8M provides a crucial buffer. The primary risk is growth deceleration from the current 28% YoY rate; with a forward PE of 26.25x, even a modest slowdown could trigger severe multiple compression. Revenue concentration is another concern, with 94.3% coming from subscriptions, making the business highly sensitive to customer retention and expansion rates. Market & Competitive Risks include valuation compression, given the stock's PS ratio of 3.04x remains above some value-oriented software peers, and its own history shows it can trade much lower. The beta of 0.77 suggests lower systematic risk, but the stock's 57.2% max drawdown proves it is susceptible to severe idiosyncratic sell-offs. Competitive disruption in the crowded customer engagement platform space is a constant threat, and the stock's recent rally makes it vulnerable to profit-taking and sector rotation out of growth names if macro conditions tighten. Worst-Case Scenario involves a combination of slowing revenue growth, a failure to achieve projected profitability, and a broader market downturn compressing SaaS multiples. This could see the stock re-test its 52-week low of $15.26, representing a -40% decline from the current $25.63 price. A breach of this level could trigger further technical selling. The chain of events would likely start with a guidance cut or earnings miss in the next quarterly report, leading to analyst downgrades from the currently unanimous bullish stance and a loss of investor confidence in the turnaround narrative.
FAQ
The key risks are, in order of severity: 1) Execution Risk: The forward PE of 26.25x demands flawless execution; any stumble in growth or profitability could cause a sharp decline. 2) Growth Deceleration: Sustaining 28% YoY growth is challenging; a slowdown below 20% would severely damage the investment thesis. 3) Competitive Pressure: The customer engagement platform space is crowded, risking pricing pressure or client attrition. 4) Market Sentiment: Despite a beta of 0.77, the stock has a -57% max drawdown, showing it is prone to severe sell-offs on negative news or sector rotation.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $26 and $32, assuming steady execution on its growth and margin targets. The Bull Case (30% probability) targets $34 to $38, driven by faster profitability and a valuation re-rating. The Bear Case (20% probability) warns of a drop to $15-$20 if growth decelerates sharply. The Base Case is most likely, anchored by the company's recent guidance raise and improving operational trends, but the wide range reflects the stock's high sensitivity to quarterly execution.
BRZE appears fairly valued to slightly undervalued relative to its growth profile. Its Price-to-Sales ratio of 3.04x is reasonable for a software company growing revenue at 28% annually, especially when compared to its own historical range above 11x. The forward PE of 26.25x implies the market expects near-term profitability, which the improving margins support. While not deeply undervalued in absolute terms, the valuation is attractive given the company's accelerating fundamentals and represents a significant discount to its post-IPO highs, suggesting the market's prior over-optimism has been fully corrected.
BRZE presents a compelling risk/reward profile for investors comfortable with turnaround growth stories. The stock is a good buy for those who believe the company's strong 27.9% revenue growth and rapid margin improvement (operating margin up to -8.2% from -24.8%) signal a durable inflection point. With a valuation at just 3.04x sales near historical lows and positive free cash flow, the downside appears limited compared to the upside if execution continues. However, it is not suitable for conservative investors due to its ongoing GAAP losses and history of high volatility, including a -57% drawdown.
BRZE is primarily suitable for a medium- to long-term investment horizon of 2-3 years. The thesis hinges on the company's multi-quarter journey to sustained profitability and a re-rating of its valuation, which will take time to unfold. Its lack of a dividend, high growth focus, and recent volatility make it a poor fit for short-term trading or income-seeking investors. The beta of 0.77 suggests lower market-correlated volatility, but the stock's own history shows significant idiosyncratic moves, requiring a patient investor willing to withstand potential swings while the fundamental story develops.